Ultra-minimally invasive prostate dilation for BPH symptoms
Part of Kidney & urinary clinical trials.
This study tests a new, minimally invasive procedure to relieve urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia or BPH). The procedure gently dilates (widens) the prostate to improve urine flow and reduce bothersome symptoms like frequent urination and weak stream.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male aged 40–80 years
- You have moderate-to-severe urinary symptoms from an enlarged prostate (IPSS score of 13 or higher)
- Your peak urine flow rate is between 5–10 mL/s, and you void at least 150 mL per time
- Your prostate volume is less than 30 mL on ultrasound
- You have normal sexual function and a sexual partner
- You can commit to follow-up visits and avoid sexual activity for 90 days after the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This trial tests a device called Optilume BPH Catheter System for men with enlarged prostate that causes bothersome urinary symptoms. It aims to see how safe and effective it is in real-world use, offering a possible treatment for blocked urine flow without surgery.
This study collects information from men who are having a minimally invasive procedure for an enlarged prostate. It helps doctors learn more about how well these treatments work and how they affect your quality of life.
This Phase 3 study tests whether treating the arteries feeding the prostate can reduce urinary symptoms from benign prostatic hyperplasia (BPH). It may help men whose BPH symptoms persist despite (or can’t be treated with) usual medications.
This trial tests a new device called the FloStent, a small tube placed in the urine channel to help men with an enlarged prostate pee more easily. It's for men who have moderate to severe symptoms and haven't had prostate surgery before.
Hear when a new BPH (Benign Prostatic Hyperplasia) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.